These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 1290288

  • 1. [Principles for the classification of anti-arrhythmia agents in cardiac arrhythmias].
    Ravens U.
    Z Kardiol; 1992; 81 Suppl 4():119-25. PubMed ID: 1290288
    [Abstract] [Full Text] [Related]

  • 2. [New aspects of the electrophysiologic effect of antiarrhythmic agents].
    Antoni H, Weirich J.
    Herz; 1990 Apr; 15(2):61-9. PubMed ID: 2188893
    [Abstract] [Full Text] [Related]

  • 3. [Current classification of anti-arrhythmia agents].
    Weirich J, Wenzel W.
    Z Kardiol; 2000 Apr; 89 Suppl 3():62-7. PubMed ID: 10810787
    [Abstract] [Full Text] [Related]

  • 4. [New aspects of the molecular effect of anti-arrhythmia agents].
    Honerjäger P.
    Herz; 1990 Apr; 15(2):70-8. PubMed ID: 2160907
    [Abstract] [Full Text] [Related]

  • 5. [Classification and mechanism of action of anti-arrhythmia drugs].
    Gasic S.
    Wien Med Wochenschr; 1994 Apr; 144(14-15):338-42. PubMed ID: 7825324
    [Abstract] [Full Text] [Related]

  • 6. Antiarrhythmic drug therapy: new drugs and changing concepts.
    Reiser HJ, Sullivan ME.
    Fed Proc; 1986 Jul; 45(8):2206-12. PubMed ID: 2873062
    [Abstract] [Full Text] [Related]

  • 7. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
    Cimponeriu A, Starmer CF, Bezerianos A.
    IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030
    [Abstract] [Full Text] [Related]

  • 8. [New aspects of frequency-dependent effect of class 1 anti-arrhythmia drugs. A critical analysis of useful subclassification].
    Weirich J, Antoni H.
    Z Kardiol; 1991 Mar; 80(3):177-86. PubMed ID: 2058249
    [Abstract] [Full Text] [Related]

  • 9. Clinical implications of new insights into mechanism of antiarrhythmic drug action.
    Meinertz T.
    J Cardiovasc Pharmacol; 1992 Mar; 20 Suppl 2():S23-7. PubMed ID: 1279305
    [Abstract] [Full Text] [Related]

  • 10. [Ventricular cardiac arrhythmias. New anti-arrhythmia agents].
    Scholz H.
    Z Kardiol; 1996 Mar; 85 Suppl 6():91-6. PubMed ID: 9064988
    [Abstract] [Full Text] [Related]

  • 11. [The pro-arrhythmia effects of anti-arrhythmia agents--theoretical and clinical aspects].
    Steinbeck G.
    Z Kardiol; 1992 Mar; 81 Suppl 4():139-43. PubMed ID: 1290290
    [Abstract] [Full Text] [Related]

  • 12. [Experimental arrhythmia models. Critical study of correlations with arrhythmias observed in clinical practice].
    Dupuis BA, Vincent AC.
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():17-27. PubMed ID: 6803699
    [Abstract] [Full Text] [Related]

  • 13. Modernized Classification of Cardiac Antiarrhythmic Drugs.
    Lei M, Wu L, Terrar DA, Huang CL.
    Circulation; 2018 Oct 23; 138(17):1879-1896. PubMed ID: 30354657
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Class III antiarrhythmic action linked with positive inotropy: antiarrhythmic, electrophysiological, and hemodynamic effects of the sea-anemone polypeptide ATX II in the dog heart in situ.
    Platou ES, Refsum H, Hotvedt R.
    J Cardiovasc Pharmacol; 1986 Oct 23; 8(3):459-65. PubMed ID: 2425158
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.